Acinetobacter Pneumonia Therapeutics Market Size, Share & Trends Report

Acinetobacter Pneumonia Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Xacduro, Polymyxins, Cephalosporins, Carbapenems), By Route Of Administration (Oral, Parenteral), By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68040-252-2
Number of Pages: 150
Format: Electronic (PDF)

Historical Range: 2018 - 2023
Industry: Healthcare

Market Segmentation

Acinetobacter Pneumonia Therapeutics Drug class Outlook (Revenue, USD Million, 2018 - 2030)
- Cephalosporins
- Fluoroquinolone
- Glycylcycline
- Carbapenem
- β-Lactam antibiotics
- Sulbactam
- Aminoglycoside
- Polymyxins
- Tetracycline
- Sulfonamide
- Others
Acinetobacter Pneumonia Therapeutics Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Parenteral
- Oral
- Others
Acinetobacter Pneumonia Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Acinetobacter Pneumonia Therapeutics Market, By Drug class
    - Cephalosporins
    - Fluoroquinolone
    - Glycylcycline
    - Carbapenem
    - β-Lactam antibiotics
    - Sulbactam
    - Aminoglycoside
    - Polymyxins
    - Tetracycline
    - Sulfonamide
    - Others
  - North America Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
    - Parenteral
    - Oral
    - Others
  - U.S.
    - U.S. Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Cephalosporins
      - Fluoroquinolone
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - U.S. Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - Canada
    - Canada Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - Canada Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
- Europe
  - Europe Acinetobacter Pneumonia Therapeutics Market, By Drug class
    - Glycylcycline
    - Carbapenem
    - β-Lactam antibiotics
    - Sulbactam
    - Aminoglycoside
    - Polymyxins
    - Tetracycline
    - Sulfonamide
    - Others
  - Europe Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
    - Parenteral
    - Oral
    - Others
  - UK
    - UK Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - UK Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - Germany
    - Germany Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - Germany Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - Spain
    - Spain Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - Spain Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - France
    - France Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - France Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - Italy
    - Italy Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - Italy Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - Denmark
    - Denmark Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - Denmark Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - Sweden
    - Sweden Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - Sweden Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - Norway
    - Norway Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - Norway Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
- Asia Pacific
  - Asia Pacific Acinetobacter Pneumonia Therapeutics Market, By Drug class
    - Glycylcycline
    - Carbapenem
    - β-Lactam antibiotics
    - Sulbactam
    - Aminoglycoside
    - Polymyxins
    - Tetracycline
    - Sulfonamide
    - Others
  - Asia Pacific Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
    - Parenteral
    - Oral
    - Others
  - Japan
    - Japan Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - Japan Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - China
    - China Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - China Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - India
    - India Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - India Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - Australia
    - Australia Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - Australia Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - Thailand
    - Thailand Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - Thailand Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - South Korea
    - South Korea Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - South Korea Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
- Latin America
  - Latin America Acinetobacter Pneumonia Therapeutics Market, By Drug class
    - Glycylcycline
    - Carbapenem
    - β-Lactam antibiotics
    - Sulbactam
    - Aminoglycoside
    - Polymyxins
    - Tetracycline
    - Sulfonamide
    - Others
  - Latin America Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
    - Parenteral
    - Oral
    - Others
  - Brazil
    - Brazil Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - Brazil Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - Mexico
    - Mexico Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - Mexico Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - Argentina
    - Argentina Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - Argentina Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
- MEA
  - MEA Acinetobacter Pneumonia Therapeutics Market, By Drug class
    - Glycylcycline
    - Carbapenem
    - β-Lactam antibiotics
    - Sulbactam
    - Aminoglycoside
    - Polymyxins
    - Tetracycline
    - Sulfonamide
    - Others
  - MEA Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
    - Parenteral
    - Oral
    - Others
  - South Africa
    - South Africa Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - South Africa Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - Saudi Arabia
  - UAE
    - UAE Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - UAE Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others
  - Kuwait
    - Kuwait Acinetobacter Pneumonia Therapeutics Market, By Drug class
      - Glycylcycline
      - Carbapenem
      - β-Lactam antibiotics
      - Sulbactam
      - Aminoglycoside
      - Polymyxins
      - Tetracycline
      - Sulfonamide
      - Others
    - Kuwait Acinetobacter Pneumonia Therapeutics Market, By Route of Administration
      - Parenteral
      - Oral
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.